Table 3.
Model | Cardiotoxicity Threshold (s) |
Balanced Accuracy | Sensitivity | Specificity | PPV | NPV | Functional | Structural | General | |
---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||||
Viability/lactic acid | 0.325 | 1.44 | 0.827 | 0.654 | 1.000 | 1.000 | 0.617 | 0.800 | 0.500 | 0.667 |
Viability/arachidonic acid | 0.675 | 1.72 | 0.744 | 0.558 | 0.931 | 0.935 | 0.540 | 0.467 | 0.500 | 0.667 |
Thymidine | 0.895 | 2.27 | 0.742 | 0.519 | 0.966 | 0.964 | 0.528 | 0.333 | 0.500 | 0.667 |
2′-Deoxycytidine | 0.865 | 1.26 | 0.810 | 0.654 | 0.966 | 0.971 | 0.609 | 0.667 | 0.500 | 0.762 |
Composite model | 1.025 | 0.862 | 0.827 | 0.897 | 0.935 | 0.743 | 0.933 | 0.625 | 0.905 |